BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancer.
| Author | |
|---|---|
| Abstract |
:
Germline mutations in the BRIP1 gene have been described as conferring a moderate risk for ovarian cancer (OC), while the role of BRIP1 in breast cancer (BC) pathogenesis remains controversial. |
| Year of Publication |
:
2018
|
| Journal |
:
Breast cancer research : BCR
|
| Volume |
:
20
|
| Issue |
:
1
|
| Number of Pages |
:
7
|
| Date Published |
:
2018
|
| ISSN Number |
:
1465-5411
|
| URL |
:
https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-018-0935-9
|
| DOI |
:
10.1186/s13058-018-0935-9
|
| Short Title |
:
Breast Cancer Res
|
| Download citation |
